Correlation Between Olema Pharmaceuticals and Armata Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Olema Pharmaceuticals and Armata Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Olema Pharmaceuticals and Armata Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Olema Pharmaceuticals and Armata Pharmaceuticals, you can compare the effects of market volatilities on Olema Pharmaceuticals and Armata Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Olema Pharmaceuticals with a short position of Armata Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Olema Pharmaceuticals and Armata Pharmaceuticals.
Diversification Opportunities for Olema Pharmaceuticals and Armata Pharmaceuticals
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Olema and Armata is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Olema Pharmaceuticals and Armata Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Armata Pharmaceuticals and Olema Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Olema Pharmaceuticals are associated (or correlated) with Armata Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Armata Pharmaceuticals has no effect on the direction of Olema Pharmaceuticals i.e., Olema Pharmaceuticals and Armata Pharmaceuticals go up and down completely randomly.
Pair Corralation between Olema Pharmaceuticals and Armata Pharmaceuticals
Given the investment horizon of 90 days Olema Pharmaceuticals is expected to under-perform the Armata Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Olema Pharmaceuticals is 1.2 times less risky than Armata Pharmaceuticals. The stock trades about -0.13 of its potential returns per unit of risk. The Armata Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 232.00 in Armata Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 3.00 from holding Armata Pharmaceuticals or generate 1.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Olema Pharmaceuticals vs. Armata Pharmaceuticals
Performance |
| Timeline |
| Olema Pharmaceuticals |
| Armata Pharmaceuticals |
Olema Pharmaceuticals and Armata Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Olema Pharmaceuticals and Armata Pharmaceuticals
The main advantage of trading using opposite Olema Pharmaceuticals and Armata Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Olema Pharmaceuticals position performs unexpectedly, Armata Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Armata Pharmaceuticals will offset losses from the drop in Armata Pharmaceuticals' long position.| Olema Pharmaceuticals vs. Sana Biotechnology | Olema Pharmaceuticals vs. Cullinan Oncology LLC | Olema Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Olema Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |